RxDoctor Payments Data

Amir Faraji

Neurological Surgery · Houston, TXNPI 1457610776

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 36.2% of the total. Reporting peaked in 2024 at $46,155 and has fallen 62.3% since, to $17,420 in 2025.

$74,464in general payments, 2019–2025

Across 329 payments — averaging $226.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$27K
  • Siemens Medical Solutions USA, Inc.$15K
  • Medtronic$14K
  • Boston Scientific$7K
  • Clearpoint Neuro, Inc.$5K
  • Insightec,inc$2K
  • plus $5K from 12 others
$44,469in research payments, 2019–2025

Across 19 payments — averaging $2340.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$34K
  • Boston Scientific$10K

What the payments were for

  • Consulting fees$19,61326%
  • Speaking & faculty fees$8,80012%
  • Travel & lodging$30,90542%
  • Food & beverage$15,01420%
  • Education$1250%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,464 in reported general payments places this provider in the 85th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$325,405
Medicare patients
245
Services billed
644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate252$1,810
Acetaminophen-CodeineAcetaminophen With Codeine130$882
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$445
Tramadol Hcl17$36

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →